ArabHealth 25-28 January, Dubai, UAE
GenoID will exhibit at ArabHealth to find partnership possibilities in the Middle-East and the neighbouring regions.
Continue readingEUROGIN, 17-20 February 2010, Monte Carlo, Monaco
Visit GenoID at EUROGIN 2010, the leading European meeting for Cervical Cancer Prevention.
Continue readingMedica, 18-21 November 2009, Düsseldorf, Germany
GenoID will be present at MEDICA, the world’s largest health care trade fair.
Continue readingCervical cancer biomarker poster at IPV 2009
“Evaluation of a new cervical screening biomarker panel” poster have been selected and published at the conference of The International Papillomavirus Society in Malmö.
Continue reading
GenoID took part at WHO HPV LabNet Study
The study found the GenoID Full Spectrum genotyping assay proficient for detection of HPV 6, 11, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and 66. The aim was to find manufacturers of HPV typing reagents worldwide who meet the requirements of producing assays with optimal sensitivity and specificity for WHO to apply in developing countries.
Continue readingPublication about GenoID’s Real-time PCR technology
The publication about GenoID’s Real-time PCR HPV Assay was published in the Journal of Virology. The technology was awarded with the Frost & Sullivan Product Innovation Award 2006 in the field of molecular biology as a milestones to detect cervical cancer.
Continue readingA particularly eventful 2007
GenoID had an outstanding year and prepares for another exciting 12 months.
Continue reading